FDA news News
Most Popular FDA news Story
Novartis' Reclast gets FDA blessing
Score one for Novartis. Its once-yearly treatment for post-menopausal osteoporosis, Reclast, now has the FDA's blessing. Already approved in the U.S. and E.U. for treatment of Paget's bone disease, Read more...
Latest Headlines
- April 7, 2009
- January 7, 2009
- May 13, 2008
- May 8, 2008
- April 22, 2008
- April 15, 2008
- April 8, 2008
- April 8, 2008
- April 3, 2008
- February 29, 2008
- January 30, 2008
- November 6, 2007
- November 2, 2007
- October 31, 2007
- October 4, 2007
- September 27, 2007
- September 24, 2007
- September 21, 2007
- September 20, 2007
- August 22, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
